[8-K] WW INTERNATIONAL, INC. Reports Material Event
WW International, Inc., known as Weight Watchers, appointed Lisa Gavales and Sue E. Gove as independent directors effective April 7, 2026.
Rhea-AI Filing Summary
WW International, Inc., known as Weight Watchers, appointed Lisa Gavales and Sue E. Gove as independent directors effective April 7, 2026. They will serve until the 2026 annual meeting and are expected to stand for election.
The Board increased to six directors, all classified as independent under Nasdaq listing standards. Each new director will receive an annual cash retainer of $90,000, plus $12,500 per year for each standing Board committee membership, with 2026 amounts prorated. Subject to their election at the 2026 annual meeting, they will be eligible for an annual restricted stock unit grant targeting $135,000 in value.
The company highlights their deep consumer, digital, turnaround and financial leadership experience to support Weight Watchers’ strategic transformation and growth focus in science-backed weight management and digital health.
Positive
- None.
Negative
- None.
8-K Event Classification
3 items: 5.02, 7.01, 9.01
3 items
Item 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers
Governance
Key personnel changes including departures, elections, or appointments of directors and executive officers.
Item 7.01
Regulation FD Disclosure
Disclosure
Material non-public information disclosed under Regulation Fair Disclosure, often investor presentations or guidance.
Item 9.01
Financial Statements and Exhibits
Exhibits
Financial statements, pro forma financial information, or exhibit attachments filed with this report.
Key Figures
Board size after appointments: 6 directors
Annual director cash retainer: $90,000
Annual committee membership retainer: $12,500
+3 more
6 metrics
Board size after appointments
6 directors
Following April 7, 2026 appointments
Annual director cash retainer
$90,000
Standard non-employee director compensation, payable quarterly
Annual committee membership retainer
$12,500
Per standing Board committee membership, payable quarterly
Target annual RSU grant
$135,000
Restricted stock units, subject to 2026 shareholder election
Experience horizon
60+ years
Weight Watchers operating history in weight management
Reference year-end for risk factors
December 31, 2025
Form 10-K risk factor period cited in forward-looking statements
Key Terms
independent director, restricted stock units, Nasdaq listing standards, forward-looking statements, +2 more
6 terms
independent director regulatory
"The Board has affirmatively determined that each of Ms. Gavales and Ms. Gove qualifies as an “independent director” under Nasdaq listing standards."
An independent director is a member of a company's board of directors who is not involved in the company's day-to-day operations and has no significant relationships with the company that could influence their judgment. Their role is to provide unbiased oversight and ensure the company is managed in the best interests of all shareholders. This helps build trust and confidence among investors by promoting transparency and accountability.
restricted stock units financial
"eligible to receive an annual equity grant of restricted stock units with a target grant date value of $135,000"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Nasdaq listing standards regulatory
"The Board has affirmatively determined that each of Ms. Gavales and Ms. Gove qualifies as an “independent director” under Nasdaq listing standards."
Nasdaq listing standards are the set of rules a company must meet to be admitted to and remain on the Nasdaq stock market, covering financial thresholds (like minimum share price and earnings), reporting and disclosure, and board and governance practices. They matter to investors because meeting these standards signals a baseline of financial health and transparency, reduces the risk of sudden delisting, and helps ensure a market with enough buyers and sellers—like a safety checklist that keeps the trading venue orderly and trustworthy.
forward-looking statements regulatory
"This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995."
Forward-looking statements are predictions or plans that companies share about what they expect to happen in the future, like estimating sales or profits. They matter because they help investors understand a company's outlook, but since they are based on guesses and assumptions, they can sometimes be wrong.
science-backed weight management financial
"the global leader in science-backed weight management, offering an integrated support system built for the GLP-1 era"
GLP-1 medications medical
"includes U.S.-based clinical interventions and access to GLP-1 medications when clinically appropriate"
GLP-1 medications are drugs that copy a natural gut hormone to help the body release insulin, lower blood sugar and reduce appetite by slowing how quickly the stomach empties. For investors, they matter because their strong clinical benefits have driven rapid sales growth, reshaped demand for diabetes and weight-loss treatments, and created regulatory, patent and pricing dynamics that can significantly affect healthcare companies’ revenues and profitability.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What board changes did WW (WW International) announce on April 7, 2026?
WW International appointed Lisa Gavales and Sue E. Gove as independent directors effective April 7, 2026. They will serve until the 2026 annual meeting of shareholders and are expected to stand for election at that meeting, bringing consumer, digital, turnaround and financial leadership experience.
How does the WW (WW International) board composition change with these appointments?
Following the appointments of Lisa Gavales and Sue Gove, the WW International Board consists of six directors. The company states that all six directors are independent under Nasdaq listing standards, emphasizing an independent oversight structure as the business pursues its strategic transformation in weight health.
What compensation will new WW (WW International) directors Lisa Gavales and Sue Gove receive?
Each director will receive an annual cash retainer of $90,000, payable quarterly, plus $12,500 per year for each standing Board committee on which she serves. These cash amounts will be prorated for fiscal 2026 based on their time on the Board and its committees.
What equity awards might WW (WW International) grant to the new directors?
Subject to their election at the 2026 annual meeting of shareholders, Lisa Gavales and Sue Gove will be eligible for an annual grant of restricted stock units with a target grant-date value of $135,000. The grant would occur on the first trading day of the company’s open trading window after the meeting.
Why did WW (WW International) highlight Lisa Gavales and Sue Gove’s backgrounds?
WW International emphasized Lisa Gavales’ experience in e-commerce, brand building and customer engagement, and Sue Gove’s operational transformation, financial leadership and public board experience. The company frames their expertise as supporting its strategic transformation and efforts to deliver long-term, sustainable growth in weight health solutions.
What forward-looking statement language does WW (WW International) include around these appointments?
WW International notes that statements about the appointments of Lisa Gavales and Sue Gove are forward-looking, subject to risks and uncertainties. It references risk factors in its Form 10-K for the year ended December 31, 2025, and subsequent SEC reports as potential drivers of materially different future outcomes.
AI-generated analysis. How Rhea-AI works. Not financial advice.
